| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
98,530,000 |
| Market
Cap: |
18.88(M) |
| Last
Volume: |
78,874 |
Avg
Vol: |
78,298 |
| 52
Week Range: |
$0.1916 - $0.1916 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Abeona Therapeutics is a clinical-stage biopharmaceutical company developing cell and gene therapies for life-threatening rare genetic diseases. Co.'s primary clinical program is EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa, which is in the pivotal Phase 3 VIITAL clinical trial. Co. is developing additional adeno-associated virus (AAV)-based gene therapies designed to treat ophthalmic and other diseases and AAV-based gene therapies using the AIM capsid platform that Co. has licensed from University of North Carolina at Chapel Hill, and internal AAV vector research programs.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
62,758 |
| Total Buy Value |
$0 |
$0 |
$0 |
$241,836 |
| Total People Bought |
0 |
0 |
0 |
5 |
| Total Buy Transactions |
0 |
0 |
0 |
6 |
| Total Shares Sold |
53,500 |
136,830 |
410,632 |
466,343 |
| Total Sell Value |
$274,482 |
$756,755 |
$2,403,310 |
$2,656,927 |
| Total People Sold |
2 |
5 |
8 |
8 |
| Total Sell Transactions |
3 |
11 |
26 |
29 |
| End Date |
2025-10-25 |
2025-07-24 |
2025-01-23 |
2024-01-24 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
Vazzano Joseph Walter |
Chief Financial Officer |
|
2026-01-22 |
4 |
S |
$5.33 |
$99,507 |
D/D |
(18,666) |
568,560 |
|
- |
|
Omalley Brendan M. |
SVP, Chief Legal Officer |
|
2026-01-22 |
4 |
S |
$5.33 |
$72,383 |
D/D |
(13,578) |
451,134 |
|
- |
|
Seshadri Vishwas |
Chief Executive Officer |
|
2026-01-22 |
4 |
S |
$5.33 |
$372,267 |
D/D |
(69,832) |
1,460,408 |
|
- |
|
Alvino Mark |
Director |
|
2026-01-21 |
4 |
S |
$5.23 |
$70,574 |
D/D |
(13,500) |
48,752 |
|
- |
|
Vazzano Joseph Walter |
Chief Financial Officer |
|
2026-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
133,595 |
587,226 |
|
- |
|
Seshadri Vishwas |
Chief Executive Officer |
|
2026-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
365,422 |
1,530,240 |
|
- |
|
Omalley Brendan M. |
SVP, Chief Legal Officer |
|
2026-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
113,949 |
464,712 |
|
- |
|
Seshadri Vishwas |
Chief Executive Officer |
|
2025-12-29 |
4 |
AS |
$5.31 |
$132,740 |
D/D |
(25,000) |
1,164,818 |
|
- |
|
Alvino Mark |
Director |
|
2025-11-13 |
4 |
S |
$4.74 |
$71,168 |
D/D |
(15,000) |
62,252 |
|
- |
|
Seshadri Vishwas |
Chief Executive Officer |
|
2025-10-16 |
4 |
S |
$5.49 |
$1,366 |
D/D |
(249) |
1,189,818 |
|
- |
|
Seshadri Vishwas |
Chief Executive Officer |
|
2025-09-30 |
4 |
AS |
$5.24 |
$130,930 |
D/D |
(25,000) |
1,190,067 |
|
- |
|
Seshadri Vishwas |
Chief Executive Officer |
|
2025-09-29 |
4 |
AS |
$5.39 |
$103,954 |
D/D |
(19,274) |
1,215,067 |
|
- |
|
Vazzano Joseph Walter |
Chief Financial Officer |
|
2025-09-29 |
4 |
S |
$5.39 |
$48,730 |
D/D |
(9,035) |
453,631 |
|
- |
|
Omalley Brendan M. |
SVP, Chief Legal Officer |
|
2025-09-29 |
4 |
S |
$5.39 |
$50,516 |
D/D |
(9,366) |
350,763 |
|
- |
|
Omalley Brendan M. |
SVP, Chief Legal Officer |
|
2025-09-22 |
4 |
S |
$5.43 |
$3,736 |
D/D |
(688) |
360,129 |
|
- |
|
Vazzano Joseph Walter |
Chief Financial Officer |
|
2025-08-15 |
4 |
S |
$7.36 |
$110,358 |
D/D |
(15,000) |
462,666 |
|
- |
|
Crombez Eric |
Director |
|
2025-08-14 |
4 |
S |
$6.93 |
$32,683 |
D/D |
(4,718) |
42,427 |
|
- |
|
Vazzano Joseph Walter |
Chief Financial Officer |
|
2025-07-22 |
4 |
S |
$6.64 |
$9,975 |
D/D |
(1,502) |
477,666 |
|
- |
|
Alvino Mark |
Director |
|
2025-07-09 |
4 |
S |
$5.86 |
$76,669 |
D/D |
(13,093) |
77,252 |
|
- |
|
Silverstein Christine Berni |
Director |
|
2025-07-09 |
4 |
S |
$5.86 |
$76,669 |
D/D |
(13,093) |
120,479 |
|
- |
|
Seshadri Vishwas |
Chief Executive Officer |
|
2025-07-09 |
4 |
S |
$5.86 |
$406,503 |
D/D |
(69,420) |
1,234,341 |
|
- |
|
Vazzano Joseph Walter |
Chief Financial Officer |
|
2025-07-09 |
4 |
S |
$5.86 |
$148,799 |
D/D |
(25,411) |
479,168 |
|
- |
|
Omalley Brendan M. |
SVP, Chief Legal Officer |
|
2025-07-09 |
4 |
S |
$5.86 |
$102,053 |
D/D |
(17,428) |
360,817 |
|
- |
|
Charles Faith L. |
Director |
|
2025-07-09 |
4 |
S |
$5.86 |
$62,879 |
D/D |
(10,738) |
139,094 |
|
- |
|
Wuchterl Donald A. |
Director |
|
2025-07-08 |
4 |
AS |
$5.82 |
$30,147 |
D/D |
(5,176) |
145,436 |
|
- |
|
219 Records found
|
|
Page 1 of 9 |
|
|